Abstract:
Embodiments herein relate to medical device systems including electric field shaping elements for use in treating cancerous tumors within a bodily tissue. In an embodiment, a medical device system for treating a cancerous tumor is described. The medical device system can include one or more electric field generating electrodes and an electric field shaping element configured to be implanted along with the one or more electric field generating electrodes. The electric field shaping element can be made from a material that alters the spatial area of tissue exposed to the electric field. Other embodiments are also included herein.
Abstract:
Embodiments herein include medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. In an embodiment, a medical device is included. The medical device can include an electric field generating circuit configured to generate one or more electric fields and control circuitry in communication with the electric field generating circuit. The control circuitry can be configured to control the generation of one or more electric fields from the electric field generating circuit. The control circuitry can cause the electric field generating circuit to deliver one or more electric fields at one or more frequencies selected from a range of between 10 kHz to 1 MHz to a cancerous tumor located within a bodily tissue. Other embodiments are also included herein.
Abstract:
A system for sensing electrical cardiac activity and for providing therapy to a patient's heart. The system may include a first implantable device implanted within a patient and a second implantable device implanted near or within the heart of the patient. In some cases, the first implantable device may at least partially power the second implantable device by periodically recharging a rechargeable battery or other power source within the second implantable device. In some cases, the first implantable device may at least partially power the second implantable device by periodically, intermittently or continuously transmitting energy that may be stored by a battery, capacitor or other power storage device within the second implantable device.
Abstract:
Systems and methods for managing communication strategies between implanted medical devices. Methods include temporal optimization relative to one or more identified conditions in the body. A selected characteristic, such as a signal representative or linked to a biological function, is assessed to determine its likely impact on communication capabilities, and one or more communication strategies may be developed to optimize intra-body communication.
Abstract:
Implantable medical devices (IMD), such as but not limited to leadless cardiac pacemakers (LCP), subcutaneous implantable cardioverter defibrillators (SICD), transvenous implantable cardioverter defibrillators, neuro-stimulators (NS), implantable monitors (IM), may be configured to communicate with each other. In some cases, a first IMD may transmit instructions to a second IMD. In order to improve the chances of a successfully received transmission, the first IMD may transmit the instructions several times during a particular time frame, such as during a single heartbeat. If the second IMD receives the message more than once, the second IMD recognizes that the messages were redundant and acts accordingly.
Abstract:
Implantable medical devices (IMD), such as but not limited to leadless cardiac pacemakers (LCP), neuro-stimulators (NS), and/or implantable monitors (IM), may be configured to communicate using more than one mode of communication and/or more than one communication vector. In some cases, the implantable medical device may be configured to switch between communication modes, vectors, and/or communication paths, which may help improve communication reliability and/or communication speed between devices.
Abstract:
Implantable medical device (IMD) such as leadless cardiac pacemakers may include a rechargeable power source. In some cases, the IMD may include a plurality of receiving coils that may capture a non-radiative near-field energy and then convert the near-field energy into electrical energy that may be used to recharge the rechargeable power source. Accordingly, since the rechargeable power source does not have to maintain sufficient energy stores in a single charge for the entire expected life of the IMD, the power source itself and thus the IMD, may be made smaller while still meeting device longevity expectations.
Abstract:
Medical device systems and methods with multiple communication modes. An example medical device system may include a first medical device and a second medical device communicatively coupled to the first medical device. The first medical device may be configured to communicate information to the second medical device in a first communication mode. The first medical device may further be configured to communicate information to the second medical device in a second communication mode after determining that one or more of the communication pulses captured the heart of the patient.